Influence of timing of cytotoxic drug treatment on the response of murine clonogenic spermatogonia to X-irradiation

Radiother Oncol. 1986 Dec;7(4):341-8. doi: 10.1016/s0167-8140(86)80064-0.

Abstract

The enhancement of radiation-induced stem spermatogonial cell killing by three cytotoxic compounds has been investigated using an in vivo clonogenic assay. Drug doses (carmustine (BCNU), 15 mg/kg; cyclophosphamide (CY), 150 mg/kg; procarbazine (PCB), 200 mg/kg) were chosen to kill a high proportion of differentiated spermatogonia but few stem-cells, as assessed by sperm-head counts (SHC) at 29 and 56 days respectively. Drug doses were administered up to 14 days prior to or after local irradiation with 9 Gy of 230 kVp X-rays. BCNU produced a moderate enhancement of damage that was relatively independent of time. Both CY and PCB produced a considerable enhancement of damage especially when administered 1 to 3 days before irradiation. Enhancement in the case of PCB consisted largely of a vertical displacement of the radiation dose-response curves, but with additional evidence for possible changes in slope.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Carmustine / pharmacology
  • Cell Survival / drug effects
  • Cell Survival / radiation effects
  • Cyclophosphamide / pharmacology
  • Dose-Response Relationship, Radiation
  • Male
  • Mice
  • Mice, Inbred CBA
  • Procarbazine / pharmacology
  • Spermatogonia / drug effects
  • Spermatogonia / radiation effects*
  • Spermatozoa / radiation effects*
  • Time Factors

Substances

  • Antineoplastic Agents
  • Procarbazine
  • Cyclophosphamide
  • Carmustine